Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: modulation of T cell costimulation

J Immunol. 1999 Mar 15;162(6):3336-41.

Abstract

Usually we rely on vaccination to promote an immune response to a pathogenic microbe. In this study, we demonstrate a suppressive from of vaccination, with DNA encoding a minigene for residues 139-151 of myelin proteolipid protein (PLP139-151), a pathogenic self-Ag. This suppressive vaccination attenuates a prototypic autoimmune disease, experimental autoimmune encephalomyelitis, which presents clinically with paralysis. Proliferative responses and production of the Th1 cytokines, IL-2 and IFN-gamma, were reduced in T cells responsive to PLP139-151. In the brains of mice that were successfully vaccinated, mRNA for IL-2, IL-15, and IFN-gamma were reduced. A mechanism underlying the reduction in severity and incidence of paralytic autoimmune disease and the reduction in Th1 cytokines involves altered costimulation of T cells; loading of APCs with DNA encoding PLP139-151 reduced the capacity of a T cell line reactive to PLP139-151 to proliferate even in the presence of exogenous CD28 costimulation. DNA immunization with the myelin minigene for PLP-altered expression of B7.1 (CD80), and B7.2 (CD86) on APCs in the spleen. Suppressive immunization against self-Ags encoded by DNA may be exploited to treat autoimmune diseases.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Autoantigens / administration & dosage
  • Autoantigens / genetics*
  • Autoantigens / immunology*
  • Base Sequence
  • Encephalomyelitis, Autoimmune, Experimental / etiology
  • Encephalomyelitis, Autoimmune, Experimental / immunology*
  • Encephalomyelitis, Autoimmune, Experimental / prevention & control*
  • Female
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / immunology*
  • Injections, Intramuscular
  • Lymphocyte Activation* / genetics
  • Mice
  • Mice, Inbred Strains
  • Molecular Sequence Data
  • Myelin Proteolipid Protein / administration & dosage
  • Myelin Proteolipid Protein / genetics
  • Myelin Proteolipid Protein / immunology
  • Peptide Fragments / administration & dosage
  • Peptide Fragments / genetics
  • Peptide Fragments / immunology
  • T-Lymphocytes / immunology*
  • Th1 Cells / immunology
  • Vaccines, DNA / administration & dosage
  • Vaccines, DNA / immunology*

Substances

  • Autoantigens
  • Immunosuppressive Agents
  • Myelin Proteolipid Protein
  • Peptide Fragments
  • Vaccines, DNA
  • myelin proteolipid protein (139-151)